From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round ...

Patients with rheumatoid arthritis and cancer seek clear information on drug safety, cancer risks, and treatment decisions, a ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at ...

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for science ...

Fatigue scores may substitute for missing data in spondyloarthritis registries, but pain and global assessments should be ...

Patients with functional anorectal pain show abnormal anal pressures, rectal hypersensitivity, and high rates of anxiety and ...

A blood test taken in the first trimester could identify women at risk of preeclampsia months before clinical signs emerge, ...

Stefan Oelrich is elected EFPIA President, as new leadership calls for action to restore Europe’s global leadership in pharma ...

Techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are increasingly recommended to guide ...

A large Japanese survey finds little evidence that cannabis leads to harder drug use, challenging the gateway hypothesis and ...

Adding breast density and polygenic risk scores to cancer assessments reclassified risk for one-third of women, with ...